Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025Accesswire • 11/06/25
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025Accesswire • 10/27/25
Down 15.4% in 4 Weeks, Here's Why Amphastar (AMPH) Looks Ripe for a TurnaroundZacks Investment Research • 10/17/25
Is the Options Market Predicting a Spike in Amphastar Pharmaceuticals Stock?Zacks Investment Research • 09/02/25
Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare ConferenceAccesswire • 08/28/25
Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales MomentumBenzinga • 08/12/25
Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.Accesswire • 08/12/25
Amphastar (AMPH) Reports Q2 Earnings: What Key Metrics Have to SayZacks Investment Research • 08/07/25
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat EstimatesZacks Investment Research • 08/07/25
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025Accesswire • 08/07/25
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025Accesswire • 07/29/25
Here's Why Amphastar (AMPH) is Poised for a Turnaround After Losing 13.1% in 4 WeeksZacks Investment Research • 07/23/25
Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga HeadquartersAccesswire • 07/14/25
Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care ConferenceAccesswire • 05/09/25
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025Accesswire • 05/07/25
Is the Options Market Predicting a Spike in Amphastar (AMPH) Stock?Zacks Investment Research • 05/01/25
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025Accesswire • 04/30/25